Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
AI In Pharma Market Size Forecast: How Large Could The Market Become By 2030?
The AI in pharma market has experienced significant expansion in recent years. Its valuation is set to climb from $3.78 billion in 2025 to $4.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.9%. This historical progression can be linked to factors such as increased pharmaceutical R&D spending, the expanding volume of biomedical data, the imperative for swifter drug development, the adoption of computational biology, and the rise in chronic diseases.
The AI in pharma market size is projected for significant expansion over the next few years. It is forecast to grow to $11.12 billion in 2030, with a compound annual growth rate (CAGR) of 23.4%. This anticipated growth can be attributed to the adoption of precision medicine, AI-based clinical trials, the demand for cost-efficient drug discovery, the growth of personalized therapies, and the integration of genomics data. Prominent trends throughout the forecast period encompass AI-driven drug discovery, clinical trial optimization, predictive disease modeling, real-time patient data analytics, and automated research and development.
Download A Free Sample Report For Comprehensive Market Insights:
AI In Pharma Market Growth Drivers: What Factors Are Accelerating Expansion?
The increased adoption of cloud-based applications and services by pharmaceutical companies is anticipated to fuel the expansion of the AI in pharma market going forward. Cloud-based drug discovery platforms represent an advanced method for conducting research and development within the pharmaceutical industry. These platforms utilize data analytics and cloud computing technologies to enhance drug discovery processes, providing a comprehensive suite of tools and functionalities vital for various facets of drug research and discovery. They significantly improve the efficiency, cost-effectiveness, and collaborative aspects of these procedures. Pharmaceutical companies are crucial market participants and end-users of these platforms, which assist them in managing extensive amounts of clinical, chemical, and biological data through secure storage solutions. For instance, in 2025, according to Eurostat, a Luxembourg-based statistical office of the European Union, in 2023, 45% of EU businesses purchased cloud computing services. Large enterprises demonstrated a considerably higher inclination towards adopting cloud solutions than SMEs, with 78% of large businesses utilizing cloud services compared to 44% of SMEs. Therefore, the expanding adoption of cloud-based applications and services by pharmaceutical companies will drive the AI in pharma market growth during the forecast period.
AI In Pharma Market Segment Analysis And Revenue Opportunities
The AI in pharma market covered in this report is segmented –
1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecule, Large Molecules
3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction
Subsegments:
1) By Context-Aware Processing: Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems
2) By Natural Language Processing (NLP): Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining
3) By Querying Method: Structured Querying, Unstructured Querying, Semantic Search Technologies
4) By Deep Learning: Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models
AI In Pharma Market Innovation Trends Driving Future Development
Major companies operating in the AI in pharma market are concentrating on developing technological advancements, such as AI-powered medical consultation enhancement tools, to improve diagnostic accuracy, streamline clinical workflows, and support timely decision-making for healthcare professionals. These AI-driven consultation aids utilize large language models (LLMs) to generate clinical summaries, automate documentation, and interpret patient-provided information, thereby optimizing physician efficiency. For instance, in October 2023, Ubie Inc., a Japan-based medical AI startup, launched a generative AI-driven feature for doctors that streamlines medical record documentation and summarizes patient findings. This feature, known as the medical interview summary function, employs an LLM to automatically condense 20–30 patient responses related to symptoms and lifestyle habits, collected through the Ubie Medical Navi platform. By presenting concise summaries directly on the doctor’s screen, the tool allows physicians to quickly understand patient concerns, reduce administrative burden, and improve the overall quality and speed of medical consultations.
AI In Pharma Market Leading Players Shaping Industry Direction
Major companies operating in the AI in pharma market are Concerto HealthAI; Alphabet Inc.; OWKIN; Nvidia Corporation; PathAI; Insilico Medicine; Exscientia; Microsoft Corporation; XtalPi; Intel; Standigm; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; DeepMind; GlaxoSmithKline; Sanofi; Bayer; Renalytix AI; Merck; AstraZeneca; Iktos; Benevolent AI; Novartis; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; IBM Corporation; Atomwise Inc.; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Cyclica; IQVIA; Roche; Pfizer; PRA Health Sciences; Oncora Medical; Recursion Pharmaceuticals Inc.; Nucleai; Pepticom; Rology; hearX Group; iNNOHEALTH Technology Solutions
Access The Complete AI In Pharma Market Report:
AI In Pharma Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the AI in pharma market in 2025. The regions covered in the AI in pharma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.